ADDvise Group publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm

09-07-2021   Regulatory press release

ADDvise Group AB (publ) issued on 21 May 2021 a senior secured bond loan of SEK 250,000,000 within a total framework amount of SEK 500,000,000 on the Swedish bond market. The bonds carry a floating rate interest of STIBOR 3m + 7.25 per cent per annum and matures 21 May 2024.

ADDvise has applied for listing of the bonds on the corporate bond list at Nasdaq Stockholm. The bonds will be admitted to trading on or about 13 July 2021.

In connection with this ADDvise has prepared a prospectus. The prospectus has been approved by the Swedish Financial Supervisory Authority. The Prospectus will be available on the Financial Supervisory Authority's website (www.fi.se) and on the company’s website (www.addvisegroup.com).

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

                     

Latest press releases

ADDvise acquires Graham Medical Technologies, LLC

Regulatory

ADDvise Group AB has today entered into a share purchase agreement with the owner of Graham Medical Technologies, LLC (“GraMedica”) regarding the acquisition of all the outstanding shares of GraMedica in accordance with the letter of intent communicated via a press release dated 10[th] May 2021. Closing of the acquisition takes place today. GraMedica’s revenue…

ADDvise Group completes a directed new share issue of approximately SEK 125 million which was multiple times oversubscribed

Regulatory

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER…

ADDvise signs Letter of Intent to acquire Southern Life Systems, Inc.

Regulatory

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Southern Life Systems, Inc. (”SLS”) regarding an acquisition of 100 percent of the shares in SLS. SLS is an American medtech company that is market leading in providing equipment and software for monitoring patients in long-term care. SLS has developed the…